Real-world outcomes post-transition to once-every-three-month paliperidone palmitate in patients with schizophrenia within US commercial plans
Emond, Bruno, El Khoury, Antoine C., Patel, Charmi, Pilon, Dominic, Morrison, Laura, Zhdanava, Maryia, Lefebvre, Patrick, Tandon, Neeta, Joshi, KrutiLanguage:
english
Journal:
Current Medical Research and Opinion
DOI:
10.1080/03007995.2018.1560220
Date:
December, 2018
File:
PDF, 1.19 MB
english, 2018